Skip to main content

Safety Alerts

By
VIROLOGICAL FAILURE IN HIV PATIENTS TREATED WITH THE COMBINATION OF DIDANOSINE, LAMIVUDINE AND TENOFOVIR
The World Health Organisation (WHO) in collaboration with the European Medical Evaluation Agency (EMEA), have issued a public statement warning about the high rate of Virologic failure in HIV patients treated with a triple nucleoside/nucleotide reverse transcriptase inhibitors combination containing Didanosine, Lamivudine and Tenofovir.
The warning statement is based on the observation of a high rate of virologic failure in a clinical study of HIV-infected patients receiving a once-day triple combination containing tenofovir (Viread, TDF), lamivudine (Epivir, 3TC) and enteric coated bedlets (Videx EC, ddI EC)
In the meantime doctors are advised as precautionary measure, NOT to use Tenofovir in combination with Didanosine and Lamivudine  when considering a new treatment regimen for therapy or treatment experienced HIV patients.
Patients already on therapy with above combination should be frequently monitored with a viral load test and considered for modification of therapy at first sign of viral load increase.
The precise nature of any interaction leading to non-response is currently unknown and is being investigated.
For further information contact TFDA
COUNTERFEIT TRIPLE ARV COMBINATION PRODUCT (GINOVIR 3D)
The Tanzania Food and Drugs Authority (TFDA) has received a warning information from the World Health Organisation (WHO) on the presence of counterfeit triple antiretroviral combination product, Ginovir 3D capsules, in Cote d’Ivoire.
The label of the medicines showed that each capsule of Ginovir 3D contained Zidovudine (200 mg), Lamivudine (150 mg) and Indinavir (40 mg). Laboratory tests however, did not show the presence of Lamivudine or Indinavir; the capsules were found to contain 201 mg of Zidovudine and 40 mg of Stavudine in addition to a non-identified substance. Labels indicated that the products were manufactured by Selchi Pharmaceuticals, P. O. Box 3351, WINDHOEK, Namibia.
TFDA would like to pass this warning statement to health care providers and the public in general as precautionary measure to stay alert to the possible presence of this product in our market.
Please communicate with TFDA once you see a similar product.

Comments

Post a Comment

Popular posts from this blog

THE OFFICE OF THE CHAIRPERSON MUHAS MID BUSINESS REPORT 2015/2016

By
INTRODUCTION Tanzania Pharmaceutical Students’ Association is a national wise association with a full membership of the International Pharmaceutical Students’ Federation (IPSF). Currently the association comprises six branches, namely Muhimbili University of Health and Allied Sciences (MUHAS), St. Johns University of Tanzania (SJUT), Catholic University of Health and Allied Sciences (CUHAS), Ruaha Catholic University (RUCU), University of Dodoma (UDOM) and currently Kilimanjaro International University (KIU) with about 1500 TAPSA members who actively participate in various activities organized by the association. As MUHAS branch we assumed our positions at the end of May 2015 after general election and only a year term. SOURCES OF FUNDS Most sources of funds are student fees, some projects like T-Shirts, TAPSA stationary, Fund raising and Donors.   ACTIVITIES OF THE ASSOCIATION IN THE YEAR 2015 Education and Practice Activities Within association we managed to conduct various tr...
Post a Comment
Read more

NO LONGER A MYTH: Octopus Soup Boosts Libido

By
  It is not a myth anymore. We now have the preliminary evidence that gives us a ray of hope to prove the same in humans. Octopus soup—supu ya pweza—can indeed boost sexual desire in men.  However, Professor Kaale is quick to warn octopus soup consumers that the new findings doesn’t mean that a cure for sexual dysfunction among men has been found. Pharmacists at Muhimbili University of Health and Allied Sciences (Muhas) say they now have scientific proof that octopus soup—popular known as supu ya pweza—can indeed boost sexual desire in men. For many years, it was widely believed by most people living along the coast of Tanzania and the wider East Africa that octopus soup increases libido among men. But there was no scientific evidence to back up their claims. “It should not be a myth anymore. We now have the preliminary evidence that gives us a ray of hope to prove the same effect in humans in further studies,” says Professor Eliangiringa Kaale, the Head of the Research...
Post a Comment
Read more

ADDO PROGRAM. Accredited Drug Dispensing Outlets in Tanzania

By
In the past,   duka la dawa baridi in Tanzania were authorized to sell nonprescription medicines. However, a 2001 assessment showed that many shops sold prescription drugs illegally and that the drug sellers were generally unqualified and untrained. In response, the Tanzania Food and Drugs Authority (TFDA) worked with Management Sciences for Health (MSH) to develop and launch the accredited drug dispensing outlet (ADDO) program—or   Duka la Dawa Muhimu —in 2003 in Ruvuma region. The goal of the ADDO program was to improve access to affordable, quality medicines and pharmaceutical services in areas where few or no registered pharmacies existed. The program’s primary activities include— Developing accreditation based on Ministry of Health and Social Welfare-instituted standards and regulations Creating a strong public sector-based regulatory and inspection system and strengthening local regulatory processes and capacity Developing drug shop owners’ business skills ...
Post a Comment
Read more